MED vs TOUR
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MED is a Sell and TOUR is a Sell.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
MED’s FA Score shows that 2 FA rating(s) are green whileTOUR’s FA Score has 0 green FA rating(s).
- MED’s FA Score: 2 green, 3 red.
- TOUR’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
MED’s TA Score shows that 4 TA indicator(s) are bullish while TOUR’s TA Score has 3 bullish TA indicator(s).
- MED’s TA Score: 4 bullish, 6 bearish.
- TOUR’s TA Score: 3 bullish, 4 bearish.
Price Growth
MED (@Other Consumer Services) experienced а +0.11% price change this week, while TOUR (@Other Consumer Services) price change was -2.86% for the same time period.
The average weekly price growth across all stocks in the @Other Consumer Services industry was +1.29%. For the same industry, the average monthly price growth was -0.15%, and the average quarterly price growth was +6.80%.
Reported Earning Dates
MED is expected to report earnings on Feb 25, 2025.
TOUR is expected to report earnings on Nov 20, 2024.
Industries' Descriptions
@Other Consumer Services (+1.29% weekly)Other consumer services include companies that provide consumer services, and are not classified elsewhere. Travel fare aggregators, hotel bookings, consumer-to-consumer or business-to-business sales platforms are some examples of services that can be clubbed into this category. Many of such services have expanded online. Booking Holdings Inc, The Priceline Group Inc, and eBay Inc. are some major operators in this segment.
| MED | TOUR | MED / TOUR | |
| Capitalization | 418M | 91.8M | 455% |
| EBITDA | 140M | -164.66M | -85% |
| Gain YTD | -72.776 | 52.012 | -140% |
| P/E Ratio | 4.12 | N/A | - |
| Revenue | 1.07B | 205M | 523% |
| Total Cash | 150M | 1.17B | 13% |
| Total Debt | 22M | 28.8M | 76% |
MED | TOUR | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 77 | 58 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 5 Undervalued | 41 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 84 | 91 | |
PRICE GROWTH RATING 1..100 | 63 | 56 | |
P/E GROWTH RATING 1..100 | 4 | 100 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MED's Valuation (5) in the Specialty Stores industry is somewhat better than the same rating for TOUR (41) in the Other Consumer Services industry. This means that MED’s stock grew somewhat faster than TOUR’s over the last 12 months.
MED's Profit vs Risk Rating (100) in the Specialty Stores industry is in the same range as TOUR (100) in the Other Consumer Services industry. This means that MED’s stock grew similarly to TOUR’s over the last 12 months.
MED's SMR Rating (84) in the Specialty Stores industry is in the same range as TOUR (91) in the Other Consumer Services industry. This means that MED’s stock grew similarly to TOUR’s over the last 12 months.
TOUR's Price Growth Rating (56) in the Other Consumer Services industry is in the same range as MED (63) in the Specialty Stores industry. This means that TOUR’s stock grew similarly to MED’s over the last 12 months.
MED's P/E Growth Rating (4) in the Specialty Stores industry is significantly better than the same rating for TOUR (100) in the Other Consumer Services industry. This means that MED’s stock grew significantly faster than TOUR’s over the last 12 months.
| MED | TOUR | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 74% | N/A |
| Stochastic ODDS (%) | 1 day ago 67% | 1 day ago 74% |
| Momentum ODDS (%) | 1 day ago 84% | 1 day ago 89% |
| MACD ODDS (%) | 1 day ago 82% | N/A |
| TrendWeek ODDS (%) | 1 day ago 67% | 1 day ago 88% |
| TrendMonth ODDS (%) | 1 day ago 71% | 1 day ago 87% |
| Advances ODDS (%) | 1 day ago 68% | 19 days ago 77% |
| Declines ODDS (%) | 4 days ago 83% | 5 days ago 86% |
| BollingerBands ODDS (%) | 1 day ago 83% | 1 day ago 81% |
| Aroon ODDS (%) | 1 day ago 73% | N/A |
MED and
Correlation & Price change
A.I.dvisor indicates that over the last year, MED has been loosely correlated with EXPE. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if MED jumps, then EXPE could also see price increases.
TOUR and
Correlation & Price change
A.I.dvisor indicates that over the last year, TOUR has been loosely correlated with SDRMF. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if TOUR jumps, then SDRMF could also see price increases.
| Ticker / NAME | Correlation To TOUR | 1D Price Change % | ||
|---|---|---|---|---|
| TOUR | 100% | -0.97% | ||
| SDRMF - TOUR | 34% Loosely correlated | N/A | ||
| TCOM - TOUR | 24% Poorly correlated | +0.59% | ||
| MED - TOUR | 22% Poorly correlated | +0.77% | ||
| CCL - TOUR | 21% Poorly correlated | +1.08% | ||
| MMYT - TOUR | 20% Poorly correlated | +2.26% | ||
More | ||||